Specifically, the observed downregulation of p53, Bax, caspase-3, and cytochrome c proteins, coupled with elevated Bcl-2 levels, aligns with the anti-apoptotic shift typically seen in tumor cells. The gene discussed is CYCS; the disease is neoplasm.